Clinical Trials Directory

Trials / Completed

CompletedNCT01139827

Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography

Status
Completed
Phase
Study type
Observational
Enrollment
178 (actual)
Sponsor
Korea University Guro Hospital · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Framingham risk score is well known screening tool that detect cardiovascular (CV) risk. But it is not suitable for CV risk in mild risk group. So 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a new imaging technique for detecting vascular inflammation within atherosclerotic plaques and hsCRP is also arising detection tool of CV risk. The investigators are examining this association in normal and impaired glucose tolerance patients groups.

Detailed description

We examined vascular inflammation using FDG-PET scan in 178 subjects (Normal and impaired glucose tolerance groups). Vascular 18F-FDG uptake was measured as both the mean and maximum blood-normalized standardized uptake value (SUV), known as the target-to-background ratio (TBR). And We analyzed that the association with Framingham risk score, hs CRP and vascular inflammation by FDG-PET scan.

Conditions

Timeline

Start date
2009-09-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2010-06-09
Last updated
2010-06-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01139827. Inclusion in this directory is not an endorsement.